Abstract
This update aims to provide an evidence based review of natural and synthetic colloids with a special emphasis on the various generations of the synthetic colloid hydroxyethyl starch. The effect of 1st, 2nd and 3rd generation hetastarches on bleeding, coagulopathy, acute kidney injury and mortality will be discussed. The results of randomised controlled trials addressing morbidity and mortality outcomes of colloid versus crystalloid resuscitation in critically ill patients will be described. In addition, the rationale and evidence behind early goal directed fluid therapy (EGDFT) including a practical approach to assessment of dynamic measures of fluid responsiveness will be presented.
Keywords: Colloids, albumin, hydroxyethylstarch, dextran, gelatins, goal directed therapy, dynamic measures, fluid responsiveness
Current Pharmaceutical Design
Title:Colloid Update
Volume: 18 Issue: 38
Author(s): Maged Y. Argalious
Affiliation:
Keywords: Colloids, albumin, hydroxyethylstarch, dextran, gelatins, goal directed therapy, dynamic measures, fluid responsiveness
Abstract: This update aims to provide an evidence based review of natural and synthetic colloids with a special emphasis on the various generations of the synthetic colloid hydroxyethyl starch. The effect of 1st, 2nd and 3rd generation hetastarches on bleeding, coagulopathy, acute kidney injury and mortality will be discussed. The results of randomised controlled trials addressing morbidity and mortality outcomes of colloid versus crystalloid resuscitation in critically ill patients will be described. In addition, the rationale and evidence behind early goal directed fluid therapy (EGDFT) including a practical approach to assessment of dynamic measures of fluid responsiveness will be presented.
Export Options
About this article
Cite this article as:
Y. Argalious Maged, Colloid Update, Current Pharmaceutical Design 2012; 18 (38) . https://dx.doi.org/10.2174/138161212803832407
DOI https://dx.doi.org/10.2174/138161212803832407 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis
Current Drug Targets Functions and Mechanisms of Green Tea Catechins in Regulating Bone Remodeling
Current Drug Targets The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy
Current Pharmaceutical Design Developmental Immunotoxicity (DIT) in Drug Safety Testing: Matching DIT Testing to Adverse Outcomes and Childhood Disease Risk
Current Drug Safety NK Cells and HIV Infection: Lessons from other Viruses
Current Molecular Medicine Recent Patents in Wine Industry
Recent Patents on Engineering Pathogenesis of Alzheimer Disease: Role of Oxidative Stress, Amyloid-β Peptides, Systemic Ammonia and Erythrocyte Energy Metabolism
CNS & Neurological Disorders - Drug Targets Cell-Selective Mitochondrial Targeting: Progress in Mitochondrial Medicine
Current Drug Delivery Serotonin (5-HT) in the Regulation of Depression-Related Emotionality: Insight from 5-HT Transporter and Tryptophan Hydroxylase-2 Knockout Mouse Models
Current Drug Targets Peptide Metabolism and the Control of Body Fluid Homeostasis
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Emerging Anabolic Treatments in Osteoporosis
Current Drug Safety Clinical Pharmacogenetics of Methotrexate
Current Drug Metabolism The RING-Finger Protein Haprin: Domains and Function in the Acrosome Reaction
Current Protein & Peptide Science The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor
Current Cancer Drug Targets Long Term Outcome of Infants with NEC
Current Pediatric Reviews Nanotechnology Advancements in the Diagnosis and Prevention of COVID-19: Past and Future
Coronaviruses Targeting Regulatory T Cells in the Treatment of Type 1 Diabetes Mellitus
Current Molecular Medicine Small RNAs Play Big Roles: MicroRNAs in Diabetic Wound Healing
Current Molecular Medicine Drug-Glycosidation and Drug Development
Mini-Reviews in Medicinal Chemistry